The detection of cardiovascular biomarkers in dermal interstitial fluid - a step to real-time monitoring - Takeaways - MDSpire

The detection of cardiovascular biomarkers in dermal interstitial fluid - a step to real-time monitoring

  • By

  • Yousaf Bhatti

  • Alireza Yazdi

  • Daniel A. Jones

  • Didier Locca

  • Pankaj Vadgama

  • Adrian Mihai Ionescu

  • Anthony Mathur

  • July 13, 2026

Share

  • 1

    Cardiovascular biomarkers are crucial for diagnosing and managing various diseases, but current methods rely on episodic venous blood sampling.

  • 2

    Dermal interstitial fluid (ISF) offers a minimally invasive alternative for continuous biomarker monitoring, potentially improving diagnostic precision.

  • 3

    Advancements in microneedle arrays, hydrogel implants, and electrokinetic extraction methods enhance the feasibility of ISF biosensing technologies.

  • 4

    Current studies show proof-of-concept for ISF-based detection of cardiac biomarkers, but clinical translation remains limited.

  • 5

    Transitioning to continuous dermal monitoring could redefine cardiovascular care by enabling earlier detection and personalized risk stratification.

Original Source(s)

The detection of cardiovascular biomarkers in dermal interstitial fluid - a step to real-time monitoring

  • by Yousaf Bhatti, Alireza Yazdi, Daniel A. Jones, Didier Locca, Pankaj Vadgama, Adrian Mihai Ionescu, Anthony Mathur

  • July 13, 2026

Related Content

Association between the fibrosis-4 index and carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus: a cross-sectional study

Comparative effectiveness of various exercise modalities on arterial stiffness and endothelial function in older adults: a systematic review and network meta-analysis of randomised controlled trials

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Recent Omicron COVID-19 Subtypes is Rare but Involves Severe Cardiovascular Features